Related references
Note: Only part of the references are listed.Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials
Bas C. Stunnenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues
Mariagrazia Roselli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies
Karen Joan Suetterlin et al.
JAMA NEUROLOGY (2015)
Mexiletine for Symptoms and Signs of Myotonia in Nondystrophic Myotonia A Randomized Controlled Trial
Jeffrey M. Statland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
E. Matthews et al.
BRAIN (2010)
The myotonic dystrophies: diagnosis and management
Chris Turner et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
E. L. Logigian et al.
NEUROLOGY (2010)
Share Paper
